Literature DB >> 7521875

Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment.

E M Coccia1, B Krust, A G Hovanessian.   

Abstract

The mechanism of action of different types of interferons (IFN-alpha, -beta, and -gamma) against human immunodeficiency virus (HIV)-1 infection was investigated in chronically infected monocytoid U937 cells and during an acute infection of the T lymphoblastoid CEM cells. Two chronically infected U937 cell populations, obtained independently (referred to as type A and B cells), were analyzed for their response to IFNs. In type A cells, IFNs mainly inhibited virus particle release, whereas in type B cells, the anti-HIV effect of IFNs cells was found to be largely due to a specific inhibition of viral protein synthesis without any apparent effect on total cellular protein synthesis. Interestingly, such a differential inhibition of HIV protein synthesis could also be demonstrated in acutely infected CEM cells in response to treatment with IFN-alpha. Both in chronically infected U937 type B and acutely infected CEM cells, equivalent amounts of nuclear and cytoplasmic HIV-1 mRNA were detected in control and IFN-treated cells in spite of at least 80% inhibition of HIV protein synthesis. Analysis of the distribution of cellular and viral mRNAs on polysomes in HIV-1-infected cells demonstrated that IFN treatment induces a specific block on viral mRNA translation. These results indicate that the antiviral mechanism of IFN on later stages of HIV replication cycle may be partly due to the inhibition of HIV mRNA translation, besides an effect on virus budding or release.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521875

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  A point of view: HIV-1/AIDS is an allergy but CpG ODN treatments may inhibit virus replication and reactivate the adaptive immunity--hypothesis and implications.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

2.  Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR.

Authors:  M Benkirane; C Neuveut; R F Chun; S M Smith; C E Samuel; A Gatignol; K T Jeang
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

3.  Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300.

Authors:  M O Hottiger; L K Felzien; G J Nabel
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

4.  Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response.

Authors:  Chi L Ong; Janine C Thorpe; Paul R Gorry; Sylvie Bannwarth; Anthony Jaworowski; Jane L Howard; Sean Chung; Shahan Campbell; Helen S Christensen; Guerline Clerzius; Andrew J Mouland; Anne Gatignol; Damian F J Purcell
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.

Authors:  Caroline Goujon; Michael H Malim
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

6.  Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection.

Authors:  V Vieillard; S Jouveshomme; N Leflour; E Jean-Pierre; P Debre; E De Maeyer; B Autran
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection.

Authors:  M Iwashiro; K Peterson; R J Messer; I M Stromnes; K J Hasenkrug
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Evidence for a different susceptibility of primate lentiviruses to type I interferons.

Authors:  Stéphanie Cordeil; Xuan-Nhi Nguyen; Gregory Berger; Stéphanie Durand; Michelle Ainouze; Andrea Cimarelli
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

9.  Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11.

Authors:  Manqing Li; Elaine Kao; Xia Gao; Hilary Sandig; Kirsten Limmer; Mariana Pavon-Eternod; Thomas E Jones; Sebastien Landry; Tao Pan; Matthew D Weitzman; Michael David
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

10.  TREX1 Knockdown Induces an Interferon Response to HIV that Delays Viral Infection in Humanized Mice.

Authors:  Lee Adam Wheeler; Radiana T Trifonova; Vladimir Vrbanac; Natasha S Barteneva; Xing Liu; Brooke Bollman; Lauren Onofrey; Sachin Mulik; Shahin Ranjbar; Andrew D Luster; Andrew M Tager; Judy Lieberman
Journal:  Cell Rep       Date:  2016-05-12       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.